145 related articles for article (PubMed ID: 6232027)
1. Serial monitoring of T-cell subset ratios with monoclonal antibodies in steroid- and antithymocyte globulin-treated patients with renal allotransplants.
Lewis RE; Kirchner K; Preuss T; Raju S; Krueger R; Cuchens M; Bower JD; Cruse JM
Clin Immunol Immunopathol; 1984 May; 31(2):241-53. PubMed ID: 6232027
[TBL] [Abstract][Full Text] [Related]
2. Ratios of T lymphocyte subpopulations predict survival of cadaveric renal allografts in adult patients on low dose corticosteroid therapy.
Van Es A; Tanke HJ; Baldwin WM; Oljans PJ; Ploem JS; Vanes LA
Clin Exp Immunol; 1983 Apr; 52(1):13-20. PubMed ID: 6345032
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of T lymphocyte subset ratios for renal transplant survival in patients on different immunosuppressive regimens.
Henny FC; van Es A; Oljans PJ; Baldwin WM; Tanke HJ; van Es LA; Paul LC
Clin Exp Immunol; 1986 Aug; 65(2):373-80. PubMed ID: 3024886
[TBL] [Abstract][Full Text] [Related]
4. Alterations in T lymphocyte subpopulations associated with renal allograft rejection.
Stelzer GT; McLeish KR; Lorden RE; Watson SL
Transplantation; 1984 Mar; 37(3):261-4. PubMed ID: 6230781
[TBL] [Abstract][Full Text] [Related]
5. Interest in and limitations of monoclonal anti-T-cell antibodies for the follow-up of renal transplant patients.
Chatenoud L; Chkoff N; Kreis H; Bach JF
Transplantation; 1983 Jul; 36(1):45-50. PubMed ID: 6191417
[TBL] [Abstract][Full Text] [Related]
6. Immunological monitoring of diabetic and nondiabetic recipients of renal allografts.
Delmonico FL; Cosimi AB; Jaffers GJ; Schooley RT; Rubin RH; Tolkoff-Rubin N; Fang LT; Russell PS
J Surg Res; 1983 Oct; 35(4):271-6. PubMed ID: 6225908
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
[TBL] [Abstract][Full Text] [Related]
8. Pretransplant thymic function predicts acute rejection in antithymocyte globulin-treated renal transplant recipients.
Bamoulid J; Courivaud C; Crepin T; Carron C; Gaiffe E; Roubiou C; Laheurte C; Moulin B; Frimat L; Rieu P; Mousson C; Durrbach A; Heng AE; Rebibou JM; Saas P; Ducloux D
Kidney Int; 2016 May; 89(5):1136-1143. PubMed ID: 27083287
[TBL] [Abstract][Full Text] [Related]
9. Antithymocyte globulin for steroid resistant rejection in renal transplant recipients immunosuppressed with triple therapy.
Richardson AJ; Higgins RM; Liddington M; Murie J; Ting A; Morris PJ
Transpl Int; 1989 Apr; 2(1):27-32. PubMed ID: 2669801
[TBL] [Abstract][Full Text] [Related]
10. [The effect of rejection crises and immunosuppressive therapy on the lymphocyte subpopulations of patients after kidney transplantation].
Kiparski Av; Frei D; Fierz W; Frei G; Uhlschmid G; Largiader F; Binswanger U
Klin Wochenschr; 1990 Apr; 68(8):408-14. PubMed ID: 1971857
[TBL] [Abstract][Full Text] [Related]
11. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.
Cosimi AB; Colvin RB; Burton RC; Rubin RH; Goldstein G; Kung PC; Hansen WP; Delmonico FL; Russell PS
N Engl J Med; 1981 Aug; 305(6):308-14. PubMed ID: 6454075
[TBL] [Abstract][Full Text] [Related]
12. The treatment of advanced cardiac allograft rejection.
Sweeney MS; Macris MP; Frazier OH; Sinnott JT; Peric M; McAllister HA
Ann Thorac Surg; 1988 Oct; 46(4):378-81. PubMed ID: 3140749
[TBL] [Abstract][Full Text] [Related]
13. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
[TBL] [Abstract][Full Text] [Related]
14. Observations on recovery of renal function following treatment for acute rejection.
Gaber AO; Moore LW; Schroeder TJ
Am J Kidney Dis; 1998 Jun; 31(6 Suppl 1):S47-59. PubMed ID: 9631864
[TBL] [Abstract][Full Text] [Related]
15. OKT4/8 ratio in the blood and in the graft during episodes of human renal allograft rejection.
von Willebrand E
Cell Immunol; 1983 Apr; 77(1):196-201. PubMed ID: 6220816
[TBL] [Abstract][Full Text] [Related]
16. Monitoring immunosuppression following renal transplantation.
Giorgi JV; Cosimi AB; Colvin RB; Goldstein G; Delmonico FL; Russell PS
Diagn Immunol; 1983; 1(3):174-8. PubMed ID: 6388969
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroid antiinflammatory agents as a substitute treatment for steroids in ATGAM-treated cadaver kidney recipients.
Kreis H; Chkoff N; Droz D; Noel LH; Tolani M; Descamps JM; Chatenoud L; Lacombe M; Crosnier J
Transplantation; 1984 Feb; 37(2):139-45. PubMed ID: 6420959
[TBL] [Abstract][Full Text] [Related]
18. Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection.
Clark KR; Forsythe JL; Shenton BK; Lennard TW; Proud G; Taylor RM
Transpl Int; 1993 Jan; 6(1):18-21. PubMed ID: 8383974
[TBL] [Abstract][Full Text] [Related]
19. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
Brennan DC; Daller JA; Lake KD; Cibrik D; Del Castillo D;
N Engl J Med; 2006 Nov; 355(19):1967-77. PubMed ID: 17093248
[TBL] [Abstract][Full Text] [Related]
20. Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantation.
Hourmant M; Le Mauff B; Cantarovich D; Dantal J; Baatard R; Denis M; Jacques Y; Karam G; Soulillou JP
Transplantation; 1994 Jan; 57(2):204-7. PubMed ID: 8310508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
